Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert McShane

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
The Cochrane Database of Systematic Reviews|July 4, 2014
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) settingJennifer K Harrison, Patricia Fearon, Anna H Noel-Storr, et al.
The Cochrane Database of Systematic Reviews|July 19, 2021
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a secondary care settingJennifer K Burton, Patricia Fearon, Anna H Noel-Storr, et al.
The Cochrane Database of Systematic Reviews|June 11, 2014
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)Craig Ritchie, Nadja Smailagic, Anna H Noel-Storr, et al.
The Cochrane Database of Systematic Reviews|November 22, 2016
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settingsJennifer K Harrison, David J Stott, Rupert McShane, et al.
Bjpsych Open|September 12, 2018
Characteristics of patients expressing an interest in ketamine treatment: results of an online surveyJolien K E Veraart, Sanne Y Smith-Apeldoorn, Hayley Trueman, et al.
The Cochrane Database of Systematic Reviews|July 18, 2021
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early detection of dementia across a variety of healthcare settingsJennifer K Burton, David J Stott, Rupert McShane, et al.
Plos Medicine|April 4, 2008
A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial)Clive Ballard, Marisa Margallo Lana, Megan Theodoulou, et al.
The Cochrane Database of Systematic Reviews|March 21, 2019
Memantine for dementiaRupert McShane, Maggie J Westby, Emmert Roberts, et al.
Journal of Psychopharmacology (Oxford, England)|April 5, 2014
Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinicPeter R Diamond, Andrew D Farmery, Stephanie Atkinson, et al.
The Cochrane Database of Systematic Reviews|September 24, 2015
Ketamine and other glutamate receptor modulators for depression in adultsCaroline Caddy, Ben H Amit, Tayla L McCloud, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
The Cochrane Database of Systematic Reviews|July 4, 2014
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) settingJennifer K Harrison, Patricia Fearon, Anna H Noel-Storr, et al.
The Cochrane Database of Systematic Reviews|July 19, 2021
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a secondary care settingJennifer K Burton, Patricia Fearon, Anna H Noel-Storr, et al.
The Cochrane Database of Systematic Reviews|June 11, 2014
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)Craig Ritchie, Nadja Smailagic, Anna H Noel-Storr, et al.
The Cochrane Database of Systematic Reviews|November 22, 2016
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settingsJennifer K Harrison, David J Stott, Rupert McShane, et al.
Bjpsych Open|September 12, 2018
Characteristics of patients expressing an interest in ketamine treatment: results of an online surveyJolien K E Veraart, Sanne Y Smith-Apeldoorn, Hayley Trueman, et al.
The Cochrane Database of Systematic Reviews|July 18, 2021
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early detection of dementia across a variety of healthcare settingsJennifer K Burton, David J Stott, Rupert McShane, et al.
Plos Medicine|April 4, 2008
A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial)Clive Ballard, Marisa Margallo Lana, Megan Theodoulou, et al.
The Cochrane Database of Systematic Reviews|March 21, 2019
Memantine for dementiaRupert McShane, Maggie J Westby, Emmert Roberts, et al.
Journal of Psychopharmacology (Oxford, England)|April 5, 2014
Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinicPeter R Diamond, Andrew D Farmery, Stephanie Atkinson, et al.
The Cochrane Database of Systematic Reviews|September 24, 2015
Ketamine and other glutamate receptor modulators for depression in adultsCaroline Caddy, Ben H Amit, Tayla L McCloud, et al.
Pageof 7